Literature DB >> 23765222

Substance P enhances HIV-1 infection in human fetal brain cell cultures expressing full-length neurokinin-1 receptor.

Lynnae Schwartz1, Sergei V Spitsin, John Meshki, Florin Tuluc, Steven D Douglas, John H Wolfe.   

Abstract

The associations between the neurokinin-1 receptor (NK-1R), substance P (SP), and HIV-1 were investigated in neurosphere-derived cultures of microglial-depleted human fetal brain cells (HFBC). Full-length NK-1R was identified in HFBC cultures. SP treatment of the HFBC increased intracellular calcium mobilization and decreased electrical impedance, both of which were blocked by the NK-1R antagonist aprepitant. SP treatment of HIV-1-infected HFBC upregulated HIV-1 expression. These data show that human neural cells grown from neurospheres express functional full length NK-1R that is responsive to SP, and that SP enhanced HIV-1 infection in HBFC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23765222      PMCID: PMC3719168          DOI: 10.1007/s13365-013-0166-x

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  41 in total

1.  Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.

Authors:  A Boutet; H Salim; Y Taoufik; P M Lledo; J D Vincent; J F Delfraissy; M Tardieu
Journal:  Glia       Date:  2001-05       Impact factor: 7.452

2.  Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.

Authors:  J P Lai; W Z Ho; G X Zhan; Y Yi; R G Collman; S D Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  Lineage pathway of human brain progenitor cells identified by JC virus susceptibility.

Authors:  Conrad A Messam; Jean Hou; Richard M Gronostajski; Eugene O Major
Journal:  Ann Neurol       Date:  2003-05       Impact factor: 10.422

Review 4.  The tachykinin peptide family.

Authors:  Cinzia Severini; Giovanna Improta; Giuliana Falconieri-Erspamer; Severo Salvadori; Vittorio Erspamer
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

5.  Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.

Authors:  F Sabri; E Tresoldi; M Di Stefano; S Polo; M C Monaco; A Verani; J R Fiore; P Lusso; E Major; F Chiodi; G Scarlatti
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

6.  Human stem cells express substance P gene and its receptor.

Authors:  Y Li; S D Douglas; W Ho
Journal:  J Hematother Stem Cell Res       Date:  2000-08

7.  Detection of substance P and its receptor in human fetal microglia.

Authors:  J P Lai; G X Zhan; D E Campbell; S D Douglas; W Z Ho
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

8.  Elevated substance P levels in HIV-infected men.

Authors:  S D Douglas; W Z Ho; D R Gettes; A Cnaan; H Zhao; J Leserman; J M Petitto; R N Golden; D L Evans
Journal:  AIDS       Date:  2001-10-19       Impact factor: 4.177

9.  Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain.

Authors:  Laura Caberlotto; Yasmin L Hurd; Paul Murdock; Jean Philippe Wahlin; Sergio Melotto; Mauro Corsi; Renzo Carletti
Journal:  Eur J Neurosci       Date:  2003-05       Impact factor: 3.386

10.  HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.

Authors:  Yun Kyung Hahn; Elizabeth M Podhaizer; Kurt F Hauser; Pamela E Knapp
Journal:  Glia       Date:  2012-08-02       Impact factor: 7.452

View more
  4 in total

1.  Substance P and Antagonists of the Neurokinin-1 Receptor in Neuroinflammation Associated with Infectious and Neurodegenerative Diseases of the Central Nervous System.

Authors:  Alejandra N Martinez; Mario T Philipp
Journal:  J Neurol Neuromedicine       Date:  2016

2.  Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathology.

Authors:  Sergei Spitsin; Kathleen E Stevens; Steven D Douglas
Journal:  J Neurol Sci       Date:  2013-08-02       Impact factor: 3.181

Review 3.  The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders.

Authors:  M Brittany Johnson; Ada D Young; Ian Marriott
Journal:  Front Cell Neurosci       Date:  2017-01-04       Impact factor: 5.505

Review 4.  The Diverse Functional Roles of Elongation Factor Tu (EF-Tu) in Microbial Pathogenesis.

Authors:  Kate L Harvey; Veronica M Jarocki; Ian G Charles; Steven P Djordjevic
Journal:  Front Microbiol       Date:  2019-10-24       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.